1. Home
  2. RLX vs WD Comparison

RLX vs WD Comparison

Compare RLX & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLX
  • WD
  • Stock Information
  • Founded
  • RLX 2018
  • WD 1937
  • Country
  • RLX China
  • WD United States
  • Employees
  • RLX N/A
  • WD N/A
  • Industry
  • RLX Medicinal Chemicals and Botanical Products
  • WD Finance: Consumer Services
  • Sector
  • RLX Health Care
  • WD Finance
  • Exchange
  • RLX Nasdaq
  • WD Nasdaq
  • Market Cap
  • RLX 3.6B
  • WD 2.4B
  • IPO Year
  • RLX 2021
  • WD 2010
  • Fundamental
  • Price
  • RLX $2.26
  • WD $73.47
  • Analyst Decision
  • RLX Hold
  • WD Hold
  • Analyst Count
  • RLX 1
  • WD 3
  • Target Price
  • RLX $2.25
  • WD $103.33
  • AVG Volume (30 Days)
  • RLX 3.9M
  • WD 318.9K
  • Earning Date
  • RLX 08-15-2025
  • WD 08-07-2025
  • Dividend Yield
  • RLX 0.43%
  • WD 3.67%
  • EPS Growth
  • RLX N/A
  • WD 6.51
  • EPS
  • RLX 0.07
  • WD 2.92
  • Revenue
  • RLX $369,684,697.00
  • WD $1,056,015,000.00
  • Revenue This Year
  • RLX $27.26
  • WD $14.45
  • Revenue Next Year
  • RLX $19.61
  • WD $6.64
  • P/E Ratio
  • RLX $33.23
  • WD $25.08
  • Revenue Growth
  • RLX 68.72
  • WD 8.64
  • 52 Week Low
  • RLX $1.50
  • WD $64.48
  • 52 Week High
  • RLX $2.69
  • WD $118.19
  • Technical
  • Relative Strength Index (RSI)
  • RLX 57.50
  • WD 57.77
  • Support Level
  • RLX $2.19
  • WD $71.81
  • Resistance Level
  • RLX $2.48
  • WD $75.47
  • Average True Range (ATR)
  • RLX 0.08
  • WD 1.90
  • MACD
  • RLX 0.00
  • WD 0.58
  • Stochastic Oscillator
  • RLX 43.75
  • WD 79.44

About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share

RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

Share on Social Networks: